Nanologica AB (publ) (STO:NICA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.400
-0.001 (-0.37%)
At close: Mar 6, 2026
-77.08%
Market Cap 35.35M
Revenue (ttm) 21.13M
Net Income (ttm) -51.29M
Shares Out 88.37M
EPS (ttm) -0.58
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 64,517
Average Volume 60,023
Open 0.393
Previous Close 0.401
Day's Range 0.388 - 0.400
52-Week Range 0.370 - 1.985
Beta -0.32
RSI 37.42
Earnings Date Feb 12, 2026

About Nanologica AB

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and pu... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 19
Stock Exchange Nasdaq Stockholm
Ticker Symbol NICA
Full Company Profile

Financial Performance

In 2025, Nanologica AB's revenue was 21.13 million, an increase of 45.32% compared to the previous year's 14.54 million. Losses were -51.29 million, -21.85% less than in 2024.

Financial Statements

News

There is no news available yet.